Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation

Abstract The objective of the present investigation was to enhance skin permeation of diclofenac using water-in-oil microemulsion and to elucidate its skin permeation mechanism. The w/o microemulsion formulations were selected based on constructed pseudoternary phase diagrams depending on water solubilization capacity and thermodynamic stability. These formulations were also subjected to physical characterization based on droplet size, viscosity, pH and conductivity. Permeation of diclofenac across rat skin using side-by-side permeation cells from selected w/o microemulsion formulations were evaluated and compared with control formulations. The selected w/o microemulsion formulations were thermodynamically stable, and incorporation of diclofenac sodium into microemulsion did not affect the phase behavior of system. All microemulsion formulations had very low viscosity (11–17 cps) and droplet size range of 30–160 nm. Microemulsion formulations exhibited statistically significant increase in diclofenac permeation compared to oily solution, aqueous solution and oil–Smix solution. Higher skin permeation of diclofenac was observed with low Smix concentration and smaller droplet size. Increase in diclofenac loading in aqueous phase decreased the partition of diclofenac. Diclofenac from the oil phase of microemulsion could directly partition into skin, while diclofenac from the aqueous droplets was carried through skin by carrier effect.

[1]  M. Gold,et al.  Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. , 2012, The American journal of geriatric pharmacotherapy.

[2]  H. Benson Skin Structure, Function, and Permeation , 2012 .

[3]  Adam C. Watkinson,et al.  Topical and Transdermal Drug Delivery: Principles and Practice , 2011 .

[4]  N. Barakat,et al.  Formulation Design of Indomethacin-Loaded Nanoemulsion ForTransdermal Delivery , 2011 .

[5]  K. Kohli,et al.  Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. , 2011, Colloids and surfaces. B, Biointerfaces.

[6]  Á. Lanas,et al.  Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. , 2010, Best practice & research. Clinical gastroenterology.

[7]  F. Ahmad,et al.  Microemulsions as a Surrogate Carrier for Dermal Drug Delivery , 2009, Drug development and industrial pharmacy.

[8]  M. Rizwan,et al.  Nanoemulsion Components Screening and Selection: a Technical Note , 2009, AAPS PharmSciTech.

[9]  F. Ahmad,et al.  Microemulsions: a novel approach to enhanced drug delivery. , 2008, Recent patents on drug delivery & formulation.

[10]  S. Baboota,et al.  Journal of Nanobiotechnology BioMed Central , 2007 .

[11]  S. Kim,et al.  N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging , 2008, Journal of nanobiotechnology.

[12]  S. Baboota,et al.  Formulation development and optimization using nanoemulsion technique: A technical note , 2007, AAPS PharmSciTech.

[13]  J. Liu,et al.  Enhancement of transdermal delivery of theophylline using microemulsion vehicle. , 2006, International journal of pharmaceutics.

[14]  Nissim Garti,et al.  Microemulsions as transdermal drug delivery vehicles. , 2006, Advances in colloid and interface science.

[15]  R. Murthy,et al.  Microemulsions: a potential drug delivery system. , 2006, Current drug delivery.

[16]  Mads Kreilgaard,et al.  Influence of microemulsions on cutaneous drug delivery. , 2002, Advanced drug delivery reviews.

[17]  S. Chi,et al.  Transdermal delivery of ketoprofen using microemulsions. , 2001, International journal of pharmaceutics.

[18]  R. Potts Skin Barrier: Principles of Percutaneous Absorption , 1997 .

[19]  M. Lawrence Surfactant systems: Microemulsions and vesicles as vehicles for drug delivery , 1994, European Journal of Drug Metabolism and Pharmacokinetics.

[20]  J. Kreuter,et al.  Colloidal Drug Delivery Systems , 1994 .

[21]  M. Scholl,et al.  Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. , 1991, British journal of clinical pharmacology.

[22]  F. Shakeel,et al.  Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. , 2010, Colloids and surfaces. B, Biointerfaces.

[23]  T. Ahmed,et al.  Pharmacokinetics of diclofenac sodium in normal man. , 2005, Pakistan journal of pharmaceutical sciences.

[24]  M. Lawrence,et al.  Microemulsion-based media as novel drug delivery systems. , 2000, Advanced drug delivery reviews.

[25]  M. Roberts,et al.  Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. , 1994, The Journal of pharmacology and experimental therapeutics.

[26]  S. Santos,et al.  Simplified micromethod for the HPLC measurement of diclofenac in plasma. , 1992, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.